We are live on ! Find out more
FBRX icon

Forte Biosciences
FBRX

75 hedge funds and large institutions have $289M invested in Forte Biosciences in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 18

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

21% more funds holding

Funds holding: 62 → 75 (+13)

6% more capital invested

Capital invested by funds: $273M → $289M (+$16.1M)

0.19% more ownership

Funds ownership: 2.36% → 2.55% (+0.19%)

Holders
75
Holders Change
+13
Holders Change %
+20.97%
% of All Funds
1.31%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
31
Increased
23
Reduced
14
Closed
18
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FAM
Fred Alger Management
New York
+$23.8M
2
BlackRock
BlackRock
New York
+$18.5M
3
State Street
State Street
Massachusetts
+$6.54M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.06M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$3.28M

Top Sellers

Rank Fund Capital Flow
1
ACH
ArrowMark Colorado Holdings
Colorado
-$7.62M
2
O
OrbiMed
New York
-$5.47M
3
Millennium Management
Millennium Management
New York
-$5.11M
4
ACM
Altium Capital Management
New York
-$4.61M
5
BI
BVF Inc
California
-$4.58M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$928K +$995K +1,104 New
Charles Schwab
27
Charles Schwab
California
$925K +$991K +1,100 New
Marshall Wace
28
Marshall Wace
United Kingdom
$893K +$732K +812 +324%
Belvedere Trading
29
Belvedere Trading
Illinois
$806K +$880K +977 New
PPA
30
Parametric Portfolio Associates
Washington
$674K +$723K +802 New
MA
31
MYDA Advisors
New York
$672K -$288K -320 -29%
Millennium Management
32
Millennium Management
New York
$641K -$5.11M -5,673 -88%
Wells Fargo
33
Wells Fargo
California
$619K +$660K +732 +24,400%
AA
34
ALPS Advisors
Colorado
$598K +$642K +712 New
IA
35
Insight Advisors
Pennsylvania
$582K +$4.51K +5 +0.7%
ACM
36
ACT Capital Management
Pennsylvania
$541K +$579K +643 New
California State Teachers Retirement System (CalSTRS)
37
California State Teachers Retirement System (CalSTRS)
California
$521K +$559K +620 New
PAM
38
Premier Asset Management
Illinois
$519K +$122K +135 +28%
TAM
39
Tocqueville Asset Management
New York
$487K +$72.1K +80 +16%
MWNA
40
Marshall Wace North America
New York
$398K -$505K -560 -54%
CIBC Private Wealth Group
41
CIBC Private Wealth Group
Georgia
$370K -$241K -267 -38%
Deutsche Bank
42
Deutsche Bank
Germany
$348K +$260K +288 +229%
LPL Financial
43
LPL Financial
California
$333K – – –
Citadel Advisors
44
Citadel Advisors
Florida
$331K -$3.8M -4,214 -91%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$326K +$350K +388 New
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$303K +$324K +360 New
Vontobel Holding
47
Vontobel Holding
Switzerland
$269K – – –
TI
48
Trexquant Investment
Connecticut
$255K +$273K +303 New
M&T Bank
49
M&T Bank
New York
$245K +$262K +291 New
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$228K +$244K +271 New
1
2
3 4

FBRX Hedge Fund Activity: Q2 2021 in Review

75 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Forte Biosciences (FBRX) for Q2 2021, worth a combined $289M — up 5.9% from $273M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new FBRX positions and 18 closed out — a net gain of 13 holders — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Fred Alger Management, adding an estimated $23.8M. The largest seller was ArrowMark Colorado Holdings, cutting an estimated $7.62M.

  • 75 institutional investors held Forte Biosciences (FBRX) as of Q2 2021, up from 62 in Q1 2021.
  • Funds reported $289M of Forte Biosciences stock for Q2 2021, up 5.9% quarter-over-quarter.
  • 31 funds opened new Forte Biosciences positions in Q2 2021 and 18 closed out, a net change of +13 holders.
  • The largest Forte Biosciences buyer in Q2 2021 was Fred Alger Management, an estimated $23.8M added.
  • The largest Forte Biosciences seller in Q2 2021 was ArrowMark Colorado Holdings, an estimated $7.62M sold.

Based on aggregated 13F filings for Q2 2021.